The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

Eli Lilly has unveiled a $27 billion (€25.7 billion) investment in US manufacturing facilities as the pharmaceutical industry ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

House Republicans advanced their budget framework for President Donald Trump’s sweeping domestic policy agenda late Tuesday, ...

Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

President Donald Trump said that he likes the idea of giving some of the savings from Elon Musk’s Department of Government ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.

President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on pharmaceutical goods, and they should start moving their manufacturing businesses ...